0 5 Human human JJ 6 16 interferon interferon NN 17 27 regulatory regulatory JJ 28 34 factor factor NN 35 36 2 2 CD 37 41 gene gene NN 41 42 . . . 43 54 Intron-exon intron-exon JJ 55 67 organization organization NN 68 71 and and CC 72 82 functional functional JJ 83 91 analysis analysis NN 92 94 of of IN 95 106 5’-flanking 5'-flanking JJ 107 113 region region NN 113 114 . . . 116 126 Interferon Interferon NNP 127 137 regulatory regulatory JJ 138 144 factor factor NN 145 146 2 2 CD 147 148 ( ( ( 148 153 IRF-2 irf-2 NN 153 154 ) ) ) 155 157 is be VBZ 158 159 a a DT 160 175 transcriptional transcriptional JJ 176 186 regulatory regulatory JJ 187 194 protein protein NN 195 199 that that WDT 200 210 terminates terminate VBZ 211 221 interferon interferon NN 222 226 beta beta NN 227 237 expression expression NN 238 247 initiated initiate VBN 248 250 by by IN 251 261 interferon interferon NN 262 272 regulatory regulatory JJ 273 279 factor factor NN 280 281 1 1 CD 281 282 . . . 283 285 In in IN 286 290 this this DT 291 296 study study NN 296 297 , , , 298 300 we we PRP 301 309 isolated isolate VBD 310 313 the the DT 314 321 genomic genomic JJ 322 325 DNA dna NN 326 329 for for IN 330 335 human human JJ 336 341 IRF-2 irf-2 NN 342 346 gene gene NN 346 347 , , , 348 358 determined determine VBD 359 362 the the DT 363 374 intron-exon intron-exon JJ 375 384 structure structure NN 385 387 of of IN 388 391 the the DT 392 397 human human JJ 398 403 IRF-2 irf-2 NN 404 408 gene gene NN 408 409 , , , 410 416 mapped map VBD 417 420 the the DT 421 426 major major JJ 427 440 transcription transcription NN 441 451 initiation initiation NN 452 456 site site NN 456 457 , , , 458 468 identified identify VBD 469 470 a a DT 471 477 number number NN 478 480 of of IN 481 490 potential potential JJ 491 501 regulatory regulatory JJ 502 510 elements element NNS 511 513 in in IN 514 517 the the DT 518 529 5’-flanking 5'-flanking JJ 530 536 region region NN 536 537 , , , 538 541 and and CC 542 551 localized localize VBD 552 555 the the DT 556 561 IRF-2 irf-2 NN 562 566 gene gene NN 567 569 on on IN 570 575 human human JJ 576 586 chromosome chromosome NN 587 588 4 4 CD 588 589 . . . 590 593 The the DT 594 599 IRF-2 irf-2 NN 600 608 promoter promoter NN 609 615 region region NN 616 624 contains contain VBZ 625 626 a a DT 627 630 CpG CpG NNP 631 637 island island NN 637 638 , , , 639 643 with with IN 644 651 several several JJ 652 654 GC GC NNP 655 660 boxes box NNS 660 661 , , , 662 663 a a DT 664 672 putative putative JJ 673 681 NF-kappa NF-kappa NNP 682 691 B-binding b-binding JJ 692 696 site site NN 696 697 , , , 698 701 and and CC 702 703 a a DT 704 708 CAAT CAAT NNP 709 712 box box NN 712 713 , , , 714 717 but but CC 718 720 no no DT 721 725 TATA TATA NNP 726 729 box box NN 729 730 . . . 731 735 When when WRB 736 739 the the DT 740 748 promoter promoter NN 749 755 region region NN 756 759 was be VBD 760 766 linked link VBN 767 771 with with IN 772 773 a a DT 774 786 heterologous heterologous JJ 787 795 reporter reporter NN 796 800 gene gene NN 800 801 , , , 802 804 we we PRP 805 810 found find VBD 811 815 that that IN 816 819 the the DT 820 828 promoter promoter NN 829 835 region region NN 836 838 is be VBZ 839 848 inducible inducible JJ 849 851 by by IN 852 856 both both DT 857 868 interferons interferon NNS 869 870 ( ( ( 870 886 interferon-alpha interferon-alpha NN 887 890 and and CC 891 897 -gamma -gamma NN 897 898 ) ) ) 899 902 and and CC 903 913 interferon interferon NN 914 924 regulatory regulatory JJ 925 931 factor factor NN 932 933 1 1 CD 933 934 . . . 935 938 The the DT 939 945 region region NN 946 951 which which WDT 952 959 induced induce VBD 960 965 these these DT 966 976 inductions induction NNS 977 980 was be VBD 981 991 identified identify VBN 992 994 as as IN 995 1000 being be VBG 1001 1009 confined confine VBN 1010 1012 to to TO 1013 1015 40 40 CD 1016 1027 nucleotides nucleotide NNS 1028 1029 5 5 CD 1029 1030 ’ ' SYM 1031 1033 to to TO 1034 1037 the the DT 1038 1043 major major JJ 1044 1059 transcriptional transcriptional JJ 1060 1070 initiation initiation NN 1071 1075 site site NN 1076 1078 by by IN 1079 1086 testing test VBG 1087 1088 a a DT 1089 1095 series series NN 1096 1098 of of IN 1099 1105 clones clone NNS 1106 1110 with with IN 1111 1120 truncated truncate VBN 1121 1129 promoter promoter NN 1130 1132 of of IN 1133 1138 IRF-2 irf-2 NN 1138 1139 . . . 1140 1144 This this DT 1145 1151 region region NN 1152 1160 contains contain VBZ 1161 1169 elements element NNS 1170 1175 which which WDT 1176 1179 are be VBP 1180 1186 shared share VBN 1187 1191 with with IN 1192 1195 the the DT 1196 1211 transcriptional transcriptional JJ 1212 1221 enhancers enhancer NNS 1222 1224 of of IN 1225 1230 other other JJ 1231 1236 genes gene NNS 1237 1246 including include VBG 1247 1257 interferon interferon NN 1258 1268 regulatory regulatory JJ 1269 1275 factor factor NN 1276 1277 1 1 CD 1277 1278 , , , 1279 1289 interferon interferon NN 1290 1294 beta beta NN 1294 1295 , , , 1296 1299 and and CC 1300 1320 interferon-inducible interferon-inducible JJ 1321 1326 genes gene NNS 1326 1327 . . . 1328 1333 These these DT 1334 1338 data datum NNS 1339 1346 suggest suggest VBP 1347 1351 that that IN 1352 1362 interferon interferon NN 1363 1373 regulatory regulatory JJ 1374 1380 factor factor NN 1381 1382 1 1 CD 1383 1386 not not RB 1387 1391 only only RB 1392 1400 triggers trigger VBZ 1401 1404 the the DT 1405 1415 activation activation NN 1416 1418 of of IN 1419 1422 the the DT 1423 1433 interferon interferon NN 1434 1440 signal signal NN 1441 1453 transduction transduction NN 1454 1461 pathway pathway NN 1461 1462 , , , 1463 1466 but but CC 1467 1471 also also RB 1472 1475 may may MD 1476 1480 play play VB 1481 1482 a a DT 1483 1487 role role NN 1488 1490 in in IN 1491 1499 limiting limit VBG 1500 1503 the the DT 1504 1512 duration duration NN 1513 1515 of of IN 1516 1520 this this DT 1521 1529 response response NN 1530 1532 by by IN 1533 1543 activating activate VBG 1544 1547 the the DT 1548 1561 transcription transcription NN 1562 1564 of of IN 1565 1570 IRF-2 irf-2 NN 1570 1571 . . .